XML 75 R56.htm IDEA: XBRL DOCUMENT v3.25.1
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 30, 2025
Mar. 31, 2024
Sales by segment of business    
Sales to customers $ 21,893 $ 21,383
Percent Change (as a percent) 2.40%  
U.S.    
Sales by segment of business    
Sales to customers $ 12,305 11,620
Percent Change (as a percent) 5.90%  
International    
Sales by segment of business    
Sales to customers $ 9,588 9,763
Percent Change (as a percent) (1.80%)  
Innovative Medicine    
Sales by segment of business    
Sales to customers $ 13,873 13,562
Percent Change (as a percent) 2.30%  
Innovative Medicine | U.S.    
Sales by segment of business    
Sales to customers $ 8,092 7,612
Percent Change (as a percent) 6.30%  
Innovative Medicine | International    
Sales by segment of business    
Sales to customers $ 5,781 5,950
Percent Change (as a percent) (2.90%)  
Innovative Medicine | Oncology    
Sales by segment of business    
Sales to customers $ 5,678 4,814
Percent Change (as a percent) 17.90%  
Innovative Medicine | Oncology | U.S.    
Sales by segment of business    
Sales to customers $ 3,013 2,383
Percent Change (as a percent) 26.40%  
Innovative Medicine | Oncology | International    
Sales by segment of business    
Sales to customers $ 2,664 2,430
Percent Change (as a percent) 9.60%  
Innovative Medicine | Oncology | CARVYKTI    
Sales by segment of business    
Sales to customers $ 369 157
Innovative Medicine | Oncology | CARVYKTI | U.S.    
Sales by segment of business    
Sales to customers 318 140
Innovative Medicine | Oncology | CARVYKTI | International    
Sales by segment of business    
Sales to customers 51 16
Innovative Medicine | Oncology | DARZALEX    
Sales by segment of business    
Sales to customers $ 3,237 2,692
Percent Change (as a percent) 20.30%  
Innovative Medicine | Oncology | DARZALEX | U.S.    
Sales by segment of business    
Sales to customers $ 1,829 1,464
Percent Change (as a percent) 24.90%  
Innovative Medicine | Oncology | DARZALEX | International    
Sales by segment of business    
Sales to customers $ 1,409 1,228
Percent Change (as a percent) 14.70%  
Innovative Medicine | Oncology | ERLEADA    
Sales by segment of business    
Sales to customers $ 771 689
Percent Change (as a percent) 11.90%  
Innovative Medicine | Oncology | ERLEADA | U.S.    
Sales by segment of business    
Sales to customers $ 292 285
Percent Change (as a percent) 2.50%  
Innovative Medicine | Oncology | ERLEADA | International    
Sales by segment of business    
Sales to customers $ 479 404
Percent Change (as a percent) 18.50%  
Innovative Medicine | Oncology | IMBRUVICA    
Sales by segment of business    
Sales to customers $ 709 784
Percent Change (as a percent) (9.50%)  
Innovative Medicine | Oncology | IMBRUVICA | U.S.    
Sales by segment of business    
Sales to customers $ 235 265
Percent Change (as a percent) (11.50%)  
Innovative Medicine | Oncology | IMBRUVICA | International    
Sales by segment of business    
Sales to customers $ 474 518
Percent Change (as a percent) (8.50%)  
Innovative Medicine | Oncology | RYBREVANT + LAZCLUZE    
Sales by segment of business    
Sales to customers $ 141 47
Innovative Medicine | Oncology | RYBREVANT + LAZCLUZE | U.S.    
Sales by segment of business    
Sales to customers 113 36
Innovative Medicine | Oncology | RYBREVANT + LAZCLUZE | International    
Sales by segment of business    
Sales to customers 28 11
Innovative Medicine | Oncology | TALVEY    
Sales by segment of business    
Sales to customers $ 86 58
Percent Change (as a percent) 48.40%  
Innovative Medicine | Oncology | TALVEY | U.S.    
Sales by segment of business    
Sales to customers $ 68 50
Percent Change (as a percent) 35.20%  
Innovative Medicine | Oncology | TALVEY | International    
Sales by segment of business    
Sales to customers $ 18 8
Innovative Medicine | Oncology | Tecvayli    
Sales by segment of business    
Sales to customers $ 151 133
Percent Change (as a percent) 13.30%  
Innovative Medicine | Oncology | Tecvayli | U.S.    
Sales by segment of business    
Sales to customers $ 105 101
Percent Change (as a percent) 4.90%  
Innovative Medicine | Oncology | Tecvayli | International    
Sales by segment of business    
Sales to customers $ 46 33
Percent Change (as a percent) 38.80%  
Innovative Medicine | Oncology | ZYTIGA    
Sales by segment of business    
Sales to customers $ 125 181
Percent Change (as a percent) (30.90%)  
Innovative Medicine | Oncology | ZYTIGA | U.S.    
Sales by segment of business    
Sales to customers $ 7 9
Percent Change (as a percent) (24.30%)  
Innovative Medicine | Oncology | ZYTIGA | International    
Sales by segment of business    
Sales to customers $ 118 172
Percent Change (as a percent) (31.30%)  
Innovative Medicine | Oncology | Other Oncology    
Sales by segment of business    
Sales to customers $ 89 73
Percent Change (as a percent) 21.70%  
Innovative Medicine | Oncology | Other Oncology | U.S.    
Sales by segment of business    
Sales to customers $ 47 33
Percent Change (as a percent) 42.90%  
Innovative Medicine | Oncology | Other Oncology | International    
Sales by segment of business    
Sales to customers $ 42 41
Percent Change (as a percent) 4.60%  
Innovative Medicine | Immunology    
Sales by segment of business    
Sales to customers $ 3,707 4,247
Percent Change (as a percent) (12.70%)  
Innovative Medicine | Immunology | U.S.    
Sales by segment of business    
Sales to customers $ 2,196 2,453
Percent Change (as a percent) (10.50%)  
Innovative Medicine | Immunology | International    
Sales by segment of business    
Sales to customers $ 1,510 1,794
Percent Change (as a percent) (15.80%)  
Innovative Medicine | Immunology | REMICADE    
Sales by segment of business    
Sales to customers $ 467 434
Percent Change (as a percent) 7.50%  
Innovative Medicine | Immunology | REMICADE | U.S.    
Sales by segment of business    
Sales to customers $ 314 266
Percent Change (as a percent) 18.10%  
Innovative Medicine | Immunology | REMICADE | U.S. Exports    
Sales by segment of business    
Sales to customers $ 10 27
Percent Change (as a percent) (64.20%)  
Innovative Medicine | Immunology | REMICADE | International    
Sales by segment of business    
Sales to customers $ 143 141
Percent Change (as a percent) 1.30%  
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA    
Sales by segment of business    
Sales to customers $ 659 554
Percent Change (as a percent) 18.90%  
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | U.S.    
Sales by segment of business    
Sales to customers $ 292 254
Percent Change (as a percent) 14.80%  
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | International    
Sales by segment of business    
Sales to customers $ 366 299
Percent Change (as a percent) 22.40%  
Innovative Medicine | Immunology | STELARA    
Sales by segment of business    
Sales to customers $ 1,625 2,451
Percent Change (as a percent) (33.70%)  
Innovative Medicine | Immunology | STELARA | U.S.    
Sales by segment of business    
Sales to customers $ 981 1,396
Percent Change (as a percent) (29.80%)  
Innovative Medicine | Immunology | STELARA | International    
Sales by segment of business    
Sales to customers $ 644 1,055
Percent Change (as a percent) (38.90%)  
Innovative Medicine | Immunology | TREMFYA    
Sales by segment of business    
Sales to customers $ 956 808
Percent Change (as a percent) 18.20%  
Innovative Medicine | Immunology | TREMFYA | U.S.    
Sales by segment of business    
Sales to customers $ 599 509
Percent Change (as a percent) 17.60%  
Innovative Medicine | Immunology | TREMFYA | International    
Sales by segment of business    
Sales to customers $ 356 299
Percent Change (as a percent) 19.20%  
Innovative Medicine | Immunology | OTHER IMMUNOLOGY    
Sales by segment of business    
Sales to customers $ 1 0
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | U.S.    
Sales by segment of business    
Sales to customers 1 0
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | International    
Sales by segment of business    
Sales to customers $ 0 0
Percent Change (as a percent) 0.00%  
Innovative Medicine | Infectious Diseases    
Sales by segment of business    
Sales to customers $ 802 821
Percent Change (as a percent) (2.20%)  
Innovative Medicine | Infectious Diseases | U.S.    
Sales by segment of business    
Sales to customers $ 315 324
Percent Change (as a percent) (2.80%)  
Innovative Medicine | Infectious Diseases | International    
Sales by segment of business    
Sales to customers $ 487 497
Percent Change (as a percent) (1.90%)  
Innovative Medicine | Infectious Diseases | EDURANT/rilpivirine    
Sales by segment of business    
Sales to customers $ 358 323
Percent Change (as a percent) 10.70%  
Innovative Medicine | Infectious Diseases | EDURANT/rilpivirine | U.S.    
Sales by segment of business    
Sales to customers $ 8 8
Percent Change (as a percent) (1.30%)  
Innovative Medicine | Infectious Diseases | EDURANT/rilpivirine | International    
Sales by segment of business    
Sales to customers $ 350 315
Percent Change (as a percent) 11.00%  
Innovative Medicine | Infectious Diseases | PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA    
Sales by segment of business    
Sales to customers $ 403 418
Percent Change (as a percent) (3.70%)  
Innovative Medicine | Infectious Diseases | PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA | U.S.    
Sales by segment of business    
Sales to customers $ 305 314
Percent Change (as a percent) (2.90%)  
Innovative Medicine | Infectious Diseases | PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA | International    
Sales by segment of business    
Sales to customers $ 98 104
Percent Change (as a percent) (6.20%)  
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES    
Sales by segment of business    
Sales to customers $ 41 78
Percent Change (as a percent) (47.60%)  
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.    
Sales by segment of business    
Sales to customers $ 2 2
Percent Change (as a percent) 7.70%  
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES | International    
Sales by segment of business    
Sales to customers $ 39 77
Percent Change (as a percent) (48.80%)  
Innovative Medicine | Neuroscience    
Sales by segment of business    
Sales to customers $ 1,647 1,803
Percent Change (as a percent) (8.60%)  
Innovative Medicine | Neuroscience | U.S.    
Sales by segment of business    
Sales to customers $ 968 1,054
Percent Change (as a percent) (8.10%)  
Innovative Medicine | Neuroscience | International    
Sales by segment of business    
Sales to customers $ 679 749
Percent Change (as a percent) (9.30%)  
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate    
Sales by segment of business    
Sales to customers $ 148 177
Percent Change (as a percent) (16.30%)  
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | U.S.    
Sales by segment of business    
Sales to customers $ 38 41
Percent Change (as a percent) (7.40%)  
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | International    
Sales by segment of business    
Sales to customers $ 110 136
Percent Change (as a percent) (18.90%)  
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA    
Sales by segment of business    
Sales to customers $ 903 1,056
Percent Change (as a percent) (14.50%)  
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S.    
Sales by segment of business    
Sales to customers $ 625 765
Percent Change (as a percent) (18.20%)  
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International    
Sales by segment of business    
Sales to customers $ 277 292
Percent Change (as a percent) (4.90%)  
Innovative Medicine | Neuroscience | SPRAVATO    
Sales by segment of business    
Sales to customers $ 320 225
Percent Change (as a percent) 41.90%  
Innovative Medicine | Neuroscience | SPRAVATO | U.S.    
Sales by segment of business    
Sales to customers $ 276 191
Percent Change (as a percent) 45.00%  
Innovative Medicine | Neuroscience | SPRAVATO | International    
Sales by segment of business    
Sales to customers $ 43 34
Percent Change (as a percent) 25.00%  
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE    
Sales by segment of business    
Sales to customers $ 277 345
Percent Change (as a percent) (19.60%)  
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | U.S.    
Sales by segment of business    
Sales to customers $ 28 58
Percent Change (as a percent) (50.60%)  
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | International    
Sales by segment of business    
Sales to customers $ 248 287
Percent Change (as a percent) (13.40%)  
Innovative Medicine | Pulmonary Hypertension    
Sales by segment of business    
Sales to customers $ 1,025 1,049
Percent Change (as a percent) (2.30%)  
Innovative Medicine | Pulmonary Hypertension | U.S.    
Sales by segment of business    
Sales to customers $ 744 766
Percent Change (as a percent) (2.90%)  
Innovative Medicine | Pulmonary Hypertension | International    
Sales by segment of business    
Sales to customers $ 281 283
Percent Change (as a percent) (0.60%)  
Innovative Medicine | Pulmonary Hypertension | OPSUMIT/OPSYNVI(2)    
Sales by segment of business    
Sales to customers $ 522 524
Percent Change (as a percent) (0.50%)  
Innovative Medicine | Pulmonary Hypertension | OPSUMIT/OPSYNVI(2) | U.S.    
Sales by segment of business    
Sales to customers $ 363 356
Percent Change (as a percent) 2.10%  
Innovative Medicine | Pulmonary Hypertension | OPSUMIT/OPSYNVI(2) | International    
Sales by segment of business    
Sales to customers $ 159 169
Percent Change (as a percent) (6.00%)  
Innovative Medicine | Pulmonary Hypertension | UPTRAVI    
Sales by segment of business    
Sales to customers $ 451 468
Percent Change (as a percent) (3.60%)  
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | U.S.    
Sales by segment of business    
Sales to customers $ 365 392
Percent Change (as a percent) (6.90%)  
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | International    
Sales by segment of business    
Sales to customers $ 86 76
Percent Change (as a percent) 13.40%  
Innovative Medicine | Pulmonary Hypertension | Other    
Sales by segment of business    
Sales to customers $ 52 56
Percent Change (as a percent) (7.20%)  
Innovative Medicine | Pulmonary Hypertension | Other | U.S.    
Sales by segment of business    
Sales to customers $ 15 18
Percent Change (as a percent) (12.70%)  
Innovative Medicine | Pulmonary Hypertension | Other | International    
Sales by segment of business    
Sales to customers $ 37 39
Percent Change (as a percent) (4.60%)  
Innovative Medicine | Cardiovascular / Metabolism / Other    
Sales by segment of business    
Sales to customers $ 1,013 829
Percent Change (as a percent) 22.30%  
Innovative Medicine | Cardiovascular / Metabolism / Other | U.S.    
Sales by segment of business    
Sales to customers $ 855 631
Percent Change (as a percent) 35.40%  
Innovative Medicine | Cardiovascular / Metabolism / Other | International    
Sales by segment of business    
Sales to customers $ 158 197
Percent Change (as a percent) (19.70%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | Other    
Sales by segment of business    
Sales to customers $ 323 311
Percent Change (as a percent) 3.90%  
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | U.S.    
Sales by segment of business    
Sales to customers $ 165 114
Percent Change (as a percent) 45.00%  
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | International    
Sales by segment of business    
Sales to customers $ 158 197
Percent Change (as a percent) (19.70%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO    
Sales by segment of business    
Sales to customers $ 690 518
Percent Change (as a percent) 33.30%  
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | U.S.    
Sales by segment of business    
Sales to customers $ 690 518
Percent Change (as a percent) 33.30%  
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | International    
Sales by segment of business    
Sales to customers $ 0 0
Percent Change (as a percent) 0.00%  
MEDTECH    
Sales by segment of business    
Sales to customers $ 8,020 7,821
Percent Change (as a percent) 2.50%  
MEDTECH | U.S.    
Sales by segment of business    
Sales to customers $ 4,213 4,008
Percent Change (as a percent) 5.10%  
MEDTECH | International    
Sales by segment of business    
Sales to customers $ 3,807 3,813
Percent Change (as a percent) (0.20%)  
MEDTECH | Cardiovascular    
Sales by segment of business    
Sales to customers $ 2,103 1,806
Percent Change (as a percent) 16.40%  
MEDTECH | Cardiovascular | U.S.    
Sales by segment of business    
Sales to customers $ 1,261 1,025
Percent Change (as a percent) 23.00%  
MEDTECH | Cardiovascular | International    
Sales by segment of business    
Sales to customers $ 842 781
Percent Change (as a percent) 7.80%  
MEDTECH | ELECTROPHYSIOLOGY    
Sales by segment of business    
Sales to customers $ 1,323 1,344
Percent Change (as a percent) (1.60%)  
MEDTECH | ELECTROPHYSIOLOGY | U.S.    
Sales by segment of business    
Sales to customers $ 684 692
Percent Change (as a percent) (1.10%)  
MEDTECH | ELECTROPHYSIOLOGY | International    
Sales by segment of business    
Sales to customers $ 638 652
Percent Change (as a percent) (2.00%)  
MEDTECH | ABIOMED    
Sales by segment of business    
Sales to customers $ 420 371
Percent Change (as a percent) 13.30%  
MEDTECH | ABIOMED | U.S.    
Sales by segment of business    
Sales to customers $ 339 303
Percent Change (as a percent) 11.90%  
MEDTECH | ABIOMED | International    
Sales by segment of business    
Sales to customers $ 81 67
Percent Change (as a percent) 19.70%  
MEDTECH | Shockwave    
Sales by segment of business    
Sales to customers $ 258 0
MEDTECH | Shockwave | U.S.    
Sales by segment of business    
Sales to customers 206 0
MEDTECH | Shockwave | International    
Sales by segment of business    
Sales to customers 52 0
MEDTECH | Other Cardiovascular    
Sales by segment of business    
Sales to customers $ 103 92
Percent Change (as a percent) 12.50%  
MEDTECH | Other Cardiovascular | U.S.    
Sales by segment of business    
Sales to customers $ 32 30
Percent Change (as a percent) 7.10%  
MEDTECH | Other Cardiovascular | International    
Sales by segment of business    
Sales to customers $ 72 62
Percent Change (as a percent) 15.10%  
MEDTECH | Orthopaedics    
Sales by segment of business    
Sales to customers $ 2,241 2,340
Percent Change (as a percent) (4.20%)  
MEDTECH | Orthopaedics | U.S.    
Sales by segment of business    
Sales to customers $ 1,384 1,448
Percent Change (as a percent) (4.40%)  
MEDTECH | Orthopaedics | International    
Sales by segment of business    
Sales to customers $ 857 892
Percent Change (as a percent) (3.90%)  
MEDTECH | Orthopaedics | HIPS    
Sales by segment of business    
Sales to customers $ 409 422
Percent Change (as a percent) (3.10%)  
MEDTECH | Orthopaedics | HIPS | U.S.    
Sales by segment of business    
Sales to customers $ 263 270
Percent Change (as a percent) (2.50%)  
MEDTECH | Orthopaedics | HIPS | International    
Sales by segment of business    
Sales to customers $ 146 152
Percent Change (as a percent) (4.00%)  
MEDTECH | Orthopaedics | KNEES    
Sales by segment of business    
Sales to customers $ 389 401
Percent Change (as a percent) (3.00%)  
MEDTECH | Orthopaedics | KNEES | U.S.    
Sales by segment of business    
Sales to customers $ 231 242
Percent Change (as a percent) (4.30%)  
MEDTECH | Orthopaedics | KNEES | International    
Sales by segment of business    
Sales to customers $ 158 160
Percent Change (as a percent) (1.00%)  
MEDTECH | Orthopaedics | TRAUMA    
Sales by segment of business    
Sales to customers $ 772 765
Percent Change (as a percent) 0.90%  
MEDTECH | Orthopaedics | TRAUMA | U.S.    
Sales by segment of business    
Sales to customers $ 502 504
Percent Change (as a percent) (0.50%)  
MEDTECH | Orthopaedics | TRAUMA | International    
Sales by segment of business    
Sales to customers $ 270 261
Percent Change (as a percent) 3.70%  
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER    
Sales by segment of business    
Sales to customers $ 671 752
Percent Change (as a percent) (10.80%)  
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 388 432
Percent Change (as a percent) (10.20%)  
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | International    
Sales by segment of business    
Sales to customers $ 283 320
Percent Change (as a percent) (11.60%)  
MEDTECH | Surgery    
Sales by segment of business    
Sales to customers $ 2,396 2,416
Percent Change (as a percent) (0.80%)  
MEDTECH | Surgery | U.S.    
Sales by segment of business    
Sales to customers $ 1,002 987
Percent Change (as a percent) 1.50%  
MEDTECH | Surgery | International    
Sales by segment of business    
Sales to customers $ 1,394 1,429
Percent Change (as a percent) (2.50%)  
MEDTECH | Surgery | ADVANCED    
Sales by segment of business    
Sales to customers $ 1,073 1,087
Percent Change (as a percent) (1.20%)  
MEDTECH | Surgery | ADVANCED | U.S.    
Sales by segment of business    
Sales to customers $ 457 446
Percent Change (as a percent) 2.70%  
MEDTECH | Surgery | ADVANCED | International    
Sales by segment of business    
Sales to customers $ 616 641
Percent Change (as a percent) (4.00%)  
MEDTECH | Surgery | GENERAL    
Sales by segment of business    
Sales to customers $ 1,323 1,330
Percent Change (as a percent) (0.50%)  
MEDTECH | Surgery | GENERAL | U.S.    
Sales by segment of business    
Sales to customers $ 544 542
Percent Change (as a percent) 0.50%  
MEDTECH | Surgery | GENERAL | International    
Sales by segment of business    
Sales to customers $ 778 788
Percent Change (as a percent) (1.20%)  
MEDTECH | Vision    
Sales by segment of business    
Sales to customers $ 1,279 1,258
Percent Change (as a percent) 1.70%  
MEDTECH | Vision | U.S.    
Sales by segment of business    
Sales to customers $ 566 547
Percent Change (as a percent) 3.40%  
MEDTECH | Vision | International    
Sales by segment of business    
Sales to customers $ 713 710
Percent Change (as a percent) 0.40%  
MEDTECH | Vision | CONTACT LENSES / OTHER    
Sales by segment of business    
Sales to customers $ 919 910
Percent Change (as a percent) 1.00%  
MEDTECH | Vision | CONTACT LENSES / OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 452 438
Percent Change (as a percent) 3.10%  
MEDTECH | Vision | CONTACT LENSES / OTHER | International    
Sales by segment of business    
Sales to customers $ 467 472
Percent Change (as a percent) (1.10%)  
MEDTECH | Vision | SURGICAL    
Sales by segment of business    
Sales to customers $ 361 348
Percent Change (as a percent) 3.70%  
MEDTECH | Vision | SURGICAL | U.S.    
Sales by segment of business    
Sales to customers $ 114 110
Percent Change (as a percent) 4.30%  
MEDTECH | Vision | SURGICAL | International    
Sales by segment of business    
Sales to customers $ 246 $ 238
Percent Change (as a percent) 3.40%